Department of Physical Chemistry of Microorganisms, Institute of Genetics and Microbiology, University of Wrocław, Przybyszewskiego 63/77, 51-148, Wrocław, Poland.
Med Microbiol Immunol. 2016 Aug;205(4):275-96. doi: 10.1007/s00430-016-0454-1. Epub 2016 Apr 5.
Cysteine proteases are one of the major classes of proteolytic enzymes involved in a number of physiological and pathological processes in plants, animals and microorganisms. When their synthesis, activity and localization in mammalian cells are altered, they may contribute to the development of many diseases, including rheumatoid arthritis, osteoporosis and cancer. Therefore, cysteine proteases have become promising drug targets for the medical treatment of these disorders. Inhibitors of cysteine proteases are also produced by almost every group of living organisms, being responsible for the control of intracellular proteolytic activity. Microorganisms synthesize cysteine protease inhibitors not only to regulate the activity of endogenous, often virulent enzymes, but also to hinder the host's proteolytic defense system and evade its immune responses against infections. Present work describes known to date microbial inhibitors of cysteine proteases in terms of their structure, enzyme binding mechanism, specificity and pathophysiological roles. The overview of both proteinaceous and small-molecule inhibitors produced by all groups of microorganisms (bacteria, archaea, fungi, protists) and viruses is provided. Subsequently, possible applications of microbial inhibitors in science, medicine and biotechnology are also highlighted.
半胱氨酸蛋白酶是参与植物、动物和微生物中许多生理和病理过程的主要蛋白酶类之一。当它们在哺乳动物细胞中的合成、活性和定位发生改变时,可能会导致许多疾病的发展,包括类风湿性关节炎、骨质疏松症和癌症。因此,半胱氨酸蛋白酶已成为治疗这些疾病的有前途的药物靶点。半胱氨酸蛋白酶抑制剂也几乎存在于所有生物群体中,负责控制细胞内蛋白水解活性。微生物合成半胱氨酸蛋白酶抑制剂不仅是为了调节内源性、通常具有毒性的酶的活性,也是为了阻碍宿主的蛋白水解防御系统并逃避其对感染的免疫反应。目前的工作根据其结构、酶结合机制、特异性和病理生理作用,描述了迄今为止已知的微生物半胱氨酸蛋白酶抑制剂。提供了所有微生物群体(细菌、古菌、真菌、原生动物)和病毒产生的蛋白质和小分子抑制剂的概述。随后,还强调了微生物抑制剂在科学、医学和生物技术中的可能应用。